Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience
Firm News | less than 1 min read | 04.21.26
Boston – April 21, 2026: Crowell & Moring advised founding investor Cure Ventures in the Series A financing of Tortugas Neuroscience, a neurology-focused biotech company.
Cure Ventures co-led the Series A round in partnership with The Column Group and AN Venture Partners. Proceeds from the financing will support Tortugas’ ongoing research and development initiatives regarding new and major neurology and neuropsychiatric disorders, including the completion of Phase 2 clinical trials for its two lead candidates.
The financing transaction was led by partner Kurt Machemer (Boston).
Read more here.
Insights
Firm News | 1 min read | 06.25.26
In Memoriam: The Honorable Rosemary Collyer (1945-2026)
It is with deep admiration that Crowell & Moring honors the life and legacy of the Honorable Rosemary Collyer, former judge of the U.S. District Court for the District of Columbia, who passed away June 7, 2026. Judge Collyer was the first woman to lead a major Washington law firm when she became Chair of Crowell in 1995.
Firm News | 1 min read | 06.22.26
Crowell & Moring Names Andrea Markstrom as Chief Information Officer
Firm News | 1 min read | 06.16.26
World Trademark Review Recognizes Four Crowell Attorneys in the 2026 Global Leaders Guide
Firm News | 2 min read | 06.11.26
Crowell & Moring Honored with Outstanding Achievement Award by the Washington Lawyers' Committee
